Aayush Wellness Appoints Directors to Enhance Board Governance

Aayush Wellness Limited's Board of Directors has approved the appointment of Mr. Dinesh Dhangare and Mr. Kashiram Jadhav as Additional Non-Executive Non-Independent Directors, effective March 31, 2026. This move aims to enhance the company's governance framework and strategic oversight.

Appointment Details

Aayush Wellness Limited announced on March 31, 2026, that its Board of Directors has approved the appointment of Mr. Dinesh Dhangare and Mr. Kashiram Jadhav. Both individuals will serve as Additional Non-Executive Non-Independent Directors, with their appointments effective immediately from March 31, 2026. The company confirmed all required SEBI disclosures for these appointments have been filed.

Mr. Dhangare brings an academic background, practical thinking, and experience in administration, compliance, and organizational processes.

Mr. Jadhav brings years of experience in administration and operations, with a practical understanding of business processes and a results-oriented approach.

Importance of the Appointments

Adding Non-Executive Non-Independent Directors (NENIDs) is crucial for corporate governance. These directors often represent the promoter or majority shareholder group, bringing industry knowledge and serving as a check on management. Their role includes safeguarding stakeholder interests and providing strategic guidance, complementing oversight from independent directors and executive management. SEBI regulations require balanced board composition, often with a minimum proportion of independent directors, highlighting the importance of strategic board appointments.

Company Background

Founded in 1984, Aayush Wellness Limited operates in the health and wellness sector, offering nutraceuticals, supplements, and preventive healthcare products. The company was formerly known as Aayush Food and Herbs Limited. Aayush Wellness has recently been expanding its business verticals, incorporating two wholly-owned subsidiaries in August 2025: Aayush Labs Private Limited for diagnostics and Aayush Ventures Private Limited for software activities. The company also reported significant financial growth for FY2024-25, with revenue surging to ₹7,338.59 lakhs (an 8645% increase) and net profit growing by 489%.

What the Appointments Mean

• Aayush Wellness Limited's board composition is enhanced with two new directors, potentially strengthening oversight.
• Mr. Dhangare and Mr. Jadhav's expertise in administration, compliance, and operations is expected to contribute to the company's strategic direction and operational efficiency.
• The appointments align with SEBI's emphasis on robust board structures for effective corporate governance.

Risks to Watch

• Aayush Wellness has been identified with 'Below Average management risk' in market analyses.
• The company's statutory auditors, M/s. AJMS & Co. LLP, resigned on February 14, 2026, which warrants close monitoring of the audit function and future auditor appointments.
• Past share disposal disclosures by a promoter in late 2023 might indicate shifts in ownership or strategy.

Peer Comparison

Key peers for Aayush Wellness in the Indian market include large FMCG players like Hindustan Unilever Ltd and Nestle India Ltd, alongside specialized wellness companies such as Zydus Wellness Ltd. These companies operate in related consumer goods and health sectors, with varying degrees of management risk and board structures.

Financial Snapshot

• Aayush Wellness reported revenue of ₹83.9 lakhs for FY2024, with a -90% CAGR in the last year.
• For FY2024-25, the company reported revenue of ₹7,338.59 lakhs, a 8645% year-on-year increase.
• Net profit for FY2024-25 stood at ₹336.58 lakhs, a 489% year-on-year growth.

What to Track Next

• Observe how the new directors contribute to board deliberations and strategic decisions.
• Monitor the company's adherence to governance norms, especially following the recent auditor resignation.
• Track the performance and integration of the newly formed diagnostic and software subsidiaries.
• Follow future board meeting outcomes for strategic announcements or policy changes.